Mendra Launches with $82 Million Series A to Acquire, Develop, and Commercialize Therapeutics for High Unmet Need Rare Diseases
Financing co-led by OrbiMed, 8VC, and 5AM Ventures with participation from Lux Capital and Wing VC to advance high-impact rare disease therapies leveraging AI SAN FRANCISCO–(BUSINESS WIRE)–Mendra, Inc. (“Mendra”), a biopharmaceutical company built to advance…